MS HB 1750
deadKratom; add to Schedule III of the Uniform Controlled Substances Act.
Mississippi · 2026 Regular Session · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did MS HB 1750 pass?
No. MS HB 1750 did not pass — it was defeated or died in the legislative process. Latest recorded action (2026-02-03): Died In Committee
What is MS HB 1750 about?
MS HB 1750 is a bill in the 2026 Regular Session titled “Kratom; add to Schedule III of the Uniform Controlled Substances Act.”.
Who sponsors MS HB 1750?
Waldo is the primary sponsor of MS HB 1750, joined by 12 cosponsors.
- Introduced
- —
- Latest action
- 2026-02-03 — Died In Committee
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Waldoprimary
- Bailey (23rd)cosponsor
- Blackwellcosponsor
- Boyd (37th)cosponsor
- Burchcosponsor
- Lottcosponsor
- Mangoldcosponsor
- Mansellcosponsor
- Remakcosponsor
- Scoggincosponsor
- Turnercosponsor
- Varnercosponsor
- Wallacecosponsor
Committees
Not provided by source.
Action timeline
Newest first
2026-02-03
Died In Committee
2026-01-28
DR - TSDP: DP To BC
2026-01-19
Referred To Drug Policy;Business and Commerce
referral-committee
Versions
- Current versionCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:25:31.732795Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MS&identifier=HB 1750. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.